Abstract:Formation of a five-membered ring aspartimide through the attack of a backbone amide to the side chain of aspartate and asparagine residues is a long-known side-reaction in solid phase peptide synthesis, and is also associated with in vivo protein ageing and instability of purified proteins. Conversely, its possible occurrence during chemical ligation-based protein synthesis, in particular when using the gold-standard reaction NCL (native chemical ligation), is dubious. We herein report a systematic study which demonstrates that the prevalence of this side-reaction may have been overlooked, due to the difficulty to identify it through standard HPLC analytical methods, but also the in situ conversion of aspar-timide into other byproducts, having the same molecular mass as the parent aspartate residue. We show that the for-mation of aspartimide and related byproducts can be limited by adopting "good NCL practices", which involve restricting the ligation temperature and reaction times, as well as replacing the commonly used phosphate buffer with HEPES. How-ever, the efficiency of such precautions is expected to vary considerably depending on the sequence of the target protein, and the amount of byproducts is expected to grow with the length of the target protein, as a result of the number of NCL reactions and potential aspartimide hotspots. To overcome such limitations, we developed a novel straightforward and potentially generally applicable methodology based on the temporary protection of the backbone nitrogen by a 2-(4-aminobutanoyloxy)-4-methoxybenzyl (GABA-Hmb) group. This strategy was validated by the byproduct-free synthesis of SUMO-2 and a SUMOylated peptide mimic.

I. Selective Protection of α- or Side-chain Carboxyl Groups of Aspartic and Glutamic Acid. A Facile Synthesis of β-Aspartyl and γ-Glutamyl Peptides

(5-Oxooxazolidin-4-yl)acetic Acid Derivatives as a Protection for the α-Carboxyl Group of Aspartic Acid: A Word of Caution

Leveraging Hydrazide as Protection for Carboxylic Acid: Suppression of Aspartimide Formation during Fmoc Solid-Phase Peptide Synthesis

Convenient Access to Glutamic Acid Side Chain Homologues Compatible with Solid Phase Peptide Synthesis.

Facile Synthesis of (S)-4-amino-5-mercaptopentanoic Acid

Synthesis of N-(Hydroxy)amide- and N-(Hydroxy)thioamide-containing Peptides.

Synthesis of Protected Dithiol Amino Acids for Potential Use in Peptide Chemistry

Suppression of alpha-carbon racemization in peptide synthesis based on a thiol-labile amino protecting group

Selective Peptide Cysteine Manipulation on Demand and Difficult Protein Chemical Synthesis Enabled by Controllable Acidolysis of N,S‐Benzylidene Thioacetals

The Enantioselective Synthesis Of Beta-Amino Acids, Their Alpha-Hydroxy Derivatives, And The N-Terminal Components Of Bestatin And Microginin

Deprotection of S-Acetamidomethyl and 1,3-Thiazolidine-4-Carbonyl Protecting Groups from Cysteine Side Chains in Peptides by <i>trans</i>-[PtX<sub>2</sub>(CN)<sub>4</sub>]<SUP>2-</SUP>: One-Pot Regioselective Synthesis of Disulfide Bonds

Synthesis and Molecular Recognition of Novel Cyclic Pseudopeptides Containing L-Glutamic Acid or L-Aspartic Acid Backbones

Efficient Preparation of Β-Hydroxy Aspartic Acid and Its Derivatives

A straightforward method to prevent the under-estimated problem of aspartimide formation during chemical ligation-mediated protein synthesis

Microwave-assisted cleavage of Alloc and Allyl Ester protecting groups in solid phase peptide synthesis

Efficient Introduction of Protected Guanidines in Boc Solid Phase Peptide Synthesis.

Concise Enantiospecific Syntheses Of Alpha-Hydroxy-Beta-Amino Acids And Indolizidines Of Natural Origin

Stereoselective Synthesis of Fully Protected (2S,4s,6s)-2-amino-6-hydroxy-4-methyl-8-oxodecanoic Acid (AHMOD).

An Fmoc-Compatible Method for Synthesis of Peptides Containing Photocaged Aspartic Acid or Glutamic Acid

Synthesis of Protected Aminoalkyl Sulfinyl Dilactones from A-Amino Acids

Access to C -protected β-amino-aldehydes via transacetalization of 6-alcoxy tetrahydrooxazinones and use for pseudo-peptide synthesis